Akums Collaborates with NIFTEM-T to Promote Research and Start-ups

Akums Drugs & Pharmaceuticals, India's leading contract development and manufacturing organization (CDMO), has signed a Memorandum of Understanding (MOU) with the National Institute of Food Technology, Entrepreneurship and Management – Thanjavur...

Glenmark’s US Growth Continues with Acetylcysteine Injection Launch

Glenmark Pharmaceuticals Ltd has also established itself in the US market by acquiring Aspen Pharma USA Inc's generic injectable Acetylcysteine. The acquisition, whose value remains confidential, aligns with Glenmark's strategy to enhance its hospita

Philips, Medtronic Partner to Train 300+ Clinicians in Heart Imaging

In India, a Memorandum of Understanding (MoU) was signed by Philips, a leader in health technology, and Medtronic, a leader in medical technology, to teach and train radiologists and cardiologists in new imaging methods for structural heart disorders

CDSCO Declares 145 Drug Samples NSQ in February 2025 Testing Results

The Central Drugs Standard Control Organization (CDSCO) issued a report that, in February 2025, a total of 145 drug samples tested throughout India were found to be of a different quality standard. The increase in the NSQ reports is attributed...

Indian Pharma Warns US Tariffs Could Raise Drug Costs, Cause Shortages

The Indian pharmaceutical industry has raised alarms over the potential imposition of US tariffs on pharmaceutical exports, warning that such a move could lead to increased drug costs and potential shortages for American consumers. Industry stalwarts

Japan's MBL Transfers Protein Test Tech to Agappe Diagnostics in India

India had to rely on the tests by imports for estimating proteins and is now being facilitated with a technology transfer from...

Biocon launches GLP-1 drug Liraglutide in the UK

Liraglutide, a GLP-1 peptide for diabetes and obesity, has been introduced in the United Kingdom (UK) by Biocon Limited, a multinational biopharmaceutical business that leads innovation. In the UK, the medication-device combination will be sold under

DCGI to Manufacturers of 2 FDCs to Submit Applications Within 3 Months

The Drugs Controller General of India (DCGI) has instructed the makers of two fixed dose combinations (FDCs) approved before 1988...

Honeywell launches AI-powered technology for Healthcare testing

Honeywell has announced a revolutionary technology, Digital Holographic Microscopy that uses artificial intelligence (AI) to quickly count and sort microscopic particles or cells. The revolutionary technology can revolutionize several industries by..

Indian pharma drives innovation to enhance its API capabilities

Indian pharmaceutical companies have been concentrating on innovation and process advancement to enhance their skills in active pharmaceutical ingredients (APIs)...

© 2025 India Pharma Outlook. All Rights Reserved.